Feb 25, 2026
Chronic Liver Disease: Understanding Cirrhosis Complications and How to Manage Them
Tag: interchangeability designation
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026
Read More
Explore how the FDA reviews biosimilars under the new 2025 guidance. Learn about the shift from clinical trials to analytical characterization, interchangeability rules, and what this means for patient access and drug costs.
